News Chart Protagonist Therapeutics, Inc.

Equities

PTGX

US74366E1029

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 16:00:00 2025-07-11 EDT			5-day change	1st Jan Change
53.00 ^USD	+0.33%		+3.82%	+37.31%

07-07	Protagonist Therapeutics, Inc. - Special Call
06-17	Citigroup Initiates Protagonist Therapeutics at Buy With $72 Price Target	MT

4ecc51396c7058c30ea.8oYLgGlOdUcgwiPkWOYsqy4Dzm_f0T3AMHictngLOao.h_B-4iEIQS1zhVquYL5ZmB1LlhiMmgWNXEv13y84W9KwvzLDLioxFUWDZg~0a0d2a099f4f66833f213d8189a25479